Pharmaceutical Pen Testing: Why R&D and GxP Need Different Scopes
R&D and GxP regulated environments have different risk profiles, compliance requirements, and testing constraints. Learn why a single unified pen test scope fails both and how to run dual-scope engagements efficiently.
Why Pen Test Evidence Fails C3PAO Assessments (and How to Fix It)
Completing a pen test isn't enough for CMMC. Learn what C3PAO assessors actually look for in your evidence package and how to align your report, scope, POA&M, and remediation docs to specific practice statements.